title: Dyslipidemia testing: Why, for whom and when.
abstract: Dyslipidemia is a major risk factor for cardiovascular disease. This review addresses why, who and when to test for dyslipidemia. The essence why to test lipids is that those individuals recognized to potentially benefit from primary cardiovascular risk prevention, have a complete cardiovascular risk assessment. Who and when to test lipids differs among the major European, English and American guidelines regarding the recommended age and approach. It is important to note that the threshold and the frequency in whom to perform risk assessment is not established. Most important in decisions concerning lipid testing is communication and to involve individual circumstances.
authors.affiliation: Pharmacology, Vascular and Metabolic Diseases Section of the Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands. Electronic address: j.galema-boers@erasmusmc.nl.
authors.forename: J M H
authors.initials: JM
authors.lastname: Galema-Boers
authors.affiliation: Pharmacology, Vascular and Metabolic Diseases Section of the Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
authors.forename: J E Roeters
authors.initials: JE
authors.lastname: van Lennep
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D006801:Humans; D008055:Lipids / Q000097:blood*; D011322:Primary Prevention; D018570:Risk Assessment
chemical_list: D008055:Lipids
keywords: Cardiovascular disease; Dyslipidemia, Familial hypercholesterolemia; Guidelines; Lipid testing, screening